Pitcairn’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-9,984
| Closed | -$450K | – | 77 |
|
|
2025
Q3 | $450K | Sell |
9,984
-20,260
| -67% | -$946K | 0.04% | 371 |
|
|
2025
Q2 | $1.4M | Sell |
30,244
-26,174
| -46% | -$1.28M | 0.09% | 207 |
|
|
2025
Q1 | $3.44M | Buy |
56,418
+1,697
| +3% | +$98.9K | 0.21% | 93 |
|
|
2024
Q4 | $3.1M | Buy |
54,721
+5,763
| +12% | +$322K | 0.18% | 100 |
|
|
2024
Q3 | $2.53M | Sell |
48,958
-1,031
| -2% | -$48.4K | 0.15% | 127 |
|
|
2024
Q2 | $2.08M | Buy |
49,989
+1,739
| +4% | +$77.8K | 0.13% | 150 |
|
|
2024
Q1 | $2.62M | Buy |
48,250
+29,128
| +152% | +$1.48M | 0.17% | 115 |
|
|
2023
Q4 | $981K | Sell |
19,122
-9,895
| -34% | -$519K | 0.07% | 243 |
|
|
2023
Q3 | $1.68M | Sell |
29,017
-6,027
| -17% | -$369K | 0.14% | 135 |
|
|
2023
Q2 | $2.24M | Sell |
35,044
-15,361
| -30% | -$1.03M | 0.19% | 100 |
|
|
2023
Q1 | $3.49M | Buy |
50,405
+6,729
| +15% | +$475K | 0.32% | 48 |
|
|
2022
Q4 | $3.14M | Buy |
43,676
+2,685
| +7% | +$202K | 0.31% | 61 |
|
|
2022
Q3 | $2.91M | Buy |
40,991
+7,919
| +24% | +$574K | 0.32% | 59 |
|
|
2022
Q2 | $2.55M | Buy |
33,072
+6,625
| +25% | +$505K | 0.27% | 74 |
|
|
2022
Q1 | $1.93M | Buy |
26,447
+5,115
| +24% | +$343K | 0.17% | 108 |
|
|
2021
Q4 | $1.33M | Sell |
21,332
-1,277
| -6% | -$74.9K | 0.09% | 170 |
|
|
2021
Q3 | $1.34M | Sell |
22,609
-3,237
| -13% | -$213K | 0.09% | 161 |
|
|
2021
Q2 | $1.73M | Buy |
25,846
+6,021
| +30% | +$393K | 0.12% | 122 |
|
|
2021
Q1 | $1.25M | Sell |
19,825
-4,351
| -18% | -$271K | 0.09% | 164 |
|
|
2020
Q4 | $1.5M | Buy |
24,176
+182
| +0.8% | +$11.2K | 0.11% | 121 |
|
|
2020
Q3 | $1.45M | Sell |
23,994
-456
| -2% | -$27.4K | 0.12% | 109 |
|
|
2020
Q2 | $1.44M | Sell |
24,450
-6,460
| -21% | -$386K | 0.14% | 97 |
|
|
2020
Q1 | $1.72M | Buy |
30,910
+2,979
| +11% | +$182K | 0.2% | 75 |
|
|
2019
Q4 | $1.79M | Buy |
27,931
+4,586
| +20% | +$263K | 0.17% | 83 |
|
|
2019
Q3 | $1.18M | Buy |
23,345
+1,650
| +8% | +$77.5K | 0.12% | 110 |
|
|
2019
Q2 | $984K | Sell |
21,695
-642
| -3% | -$29.9K | 0.1% | 132 |
|
|
2019
Q1 | $1.06M | Buy |
22,337
+6,006
| +37% | +$299K | 0.12% | 108 |
|
|
2018
Q4 | $849K | Sell |
16,331
-5,625
| -26% | -$302K | 0.09% | 129 |
|
|
2018
Q3 | $1.36M | Buy |
21,956
+6,276
| +40% | +$372K | 0.14% | 98 |
|
|
2018
Q2 | $867K | Sell |
15,680
-381
| -2% | -$20.6K | 0.09% | 149 |
|
|
2018
Q1 | $1.02M | Sell |
16,061
-279
| -2% | -$17.9K | 0.11% | 118 |
|
|
2017
Q4 | $1M | Buy |
16,340
+185
| +1% | +$11.6K | 0.1% | 143 |
|
|
2017
Q3 | $1.03M | Buy |
16,155
+132
| +0.8% | +$7.71K | 0.12% | 121 |
|
|
2017
Q2 | $893K | Sell |
16,023
-6,339
| -28% | -$345K | 0.11% | 132 |
|
|
2017
Q1 | $1.22M | Sell |
22,362
-133
| -0.6% | -$7.29K | 0.15% | 106 |
|
|
2016
Q4 | $1.31M | Sell |
22,495
-664
| -3% | -$36.3K | 0.16% | 94 |
|
|
2016
Q3 | $1.25M | Sell |
23,159
-34,811
| -60% | -$2.24M | 0.16% | 99 |
|
|
2016
Q2 | $4.26M | Buy |
57,970
+8,510
| +17% | +$601K | 0.55% | 21 |
|
|
2016
Q1 | $3.16M | Sell |
49,460
-5,899
| -11% | -$372K | 0.4% | 29 |
|
|
2015
Q4 | $3.81M | Buy |
55,359
+442
| +0.8% | +$29.2K | 0.42% | 29 |
|
|
2015
Q3 | $3.25M | Buy |
54,917
+17,481
| +47% | +$1.11M | 0.43% | 26 |
|
|
2015
Q2 | $2.49M | Buy |
37,436
+1,696
| +5% | +$112K | 0.29% | 63 |
|
|
2015
Q1 | $2.31M | Buy |
35,740
+2,785
| +8% | +$174K | 0.25% | 70 |
|
|
2014
Q4 | $1.95M | Buy |
32,955
+16,574
| +101% | +$935K | 0.21% | 90 |
|
|
2014
Q3 | $839K | Sell |
16,381
-104
| -0.6% | -$5.2K | 0.09% | 170 |
|
|
2014
Q2 | $800K | Sell |
16,485
-21
| -0.1% | -$1.03K | 0.09% | 181 |
|
|
2014
Q1 | $857K | Sell |
16,506
-5,316
| -24% | -$283K | 0.1% | 168 |
|
|
2013
Q4 | $1.16M | Buy |
21,822
+5,006
| +30% | +$255K | 0.13% | 135 |
|
|
2013
Q3 | $778K | Sell |
16,816
-454
| -3% | -$19.9K | 0.1% | 163 |
|
|
2013
Q2 | $772K | Buy |
+17,270
| New | +$750K | 0.1% | 183 |
|
Other funds holding BMY
Pitcairn's BMY Position: Q4 2025 in Review
Pitcairn sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 9,984 shares — an estimated $450K sold.
Pitcairn first reported a position in BMY in Q2 2013 and held it in 50 quarters. The position peaked at $4.26M in Q2 2016. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Pitcairn reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Pitcairn sold 9,984 Bristol-Myers Squibb shares in Q4 2025, an estimated $450K.
- Pitcairn first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 50 quarters.
- Pitcairn's Bristol-Myers Squibb position peaked at $4.26M in Q2 2016.
- 2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Pitcairn's 13F filing for Q4 2025.